Showing results (2181-2190 of 5,939) with videos related to
Sort By:
Pageof 594
The Prostate|September 16, 2004
Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumorsStephen R Plymate, Marie K Tennant, Stephen H Culp, et al.The Prostate|September 16, 2004
CVS-3983, a selective matriptase inhibitor, suppresses the growth of androgen independent prostate tumor xenograftsAnna V Galkin, Lynne Mullen, William D Fox, et al.The Prostate|September 16, 2004
Plasma levels of transforming growth factor-1beta and alpha2-macroglobulin before and after radical prostatectomy: association to clinicopathological parametersO Sinnreich, J Kratzsch, A Reichenbach, et al.The Prostate|September 25, 2004
Comparison of the zones of the human prostate with the seminal vesicle: morphology, immunohistochemistry, and cell kineticsIstván Laczkó, David L Hudson, Alex Freeman, et al.The Prostate|September 25, 2004
Castration triggers growth of previously static androgen-independent lesions in the transgenic adenocarcinoma of the mouse prostate (TRAMP) modelMac A Johnson, Philip Iversen, Phillip Schwier, et al.The Prostate|September 25, 2004
Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccineAnna-Karin Roos, Maxim Pavlenko, Jehad Charo, et al.The Prostate|September 25, 2004
Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancerDan Leibovici, Ashish M Kamat, Kim A Do, et al.The Prostate|September 25, 2004
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancerNoboru Hara, Mina Okuizumi, Hiroshi Koike, et al.The Prostate|September 25, 2004
Increased sensitivity of a metastatic model of prostate cancer to a novel tetravalent platinum analogKalpana Mujoo, Masayuki Watanabe, Abdul R Khokhar, et al.The Prostate|September 25, 2004
The potential value of (Myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinomaDavor Tomas, Bozo KruslinPageof 594